CorMedix Inc.
Company Stats
- Market Cap
- $600.2M
- as of Sep 30, 2026
- Shares Outstanding
- 77.9M
- Free Float
- 94.8%
Income Statement
- Revenue
- $311.7M
- Operating Income
- $150.1M
- Net Income
- $163.1M
- EBITDA
- $150.8M
- Revenue Growth, 3Y
- 1582.8%
Cash Flow
- Free Cash Flow
- $172.8M
- FCF Yield
- 28.8%
- Owner FCF Yield
- 26.5%
Balance Sheet
- Cash & Equivalents
- $144.8M
Returns & Capital
- SBC, 3Y Avg
- $8.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $311.7M | $172.8M | 55.4% |
| FY2024 | $43.5M | -$50.7M | -116.7% |
| FY2023 | — | -$38.7M | — |
| FY2022 | $65,408 | -$24.6M | -37573.5% |
| FY2021 | $190,936 | -$22.6M | -11826.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 11, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges